Malaysian Genomics Sees Rise in Profit Margins for 1Q
The Group recorded a 254.16% increase in profit before tax (PBT) to RM0.85 million for 1Q 2023, compared with RM0.24 million in the corresponding quarter
revenue contributions from the new biopharmaceutical business